Neurocrine Clinical Site

Oklahoma City, Oklahoma 73112

Use our guide to learn which trials are right for you!

We've found
5 trials
at this facility
Tourette Syndrome Clinical Trial
Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tourette Syndrome Clinical Trial
Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tardive Dyskinesia (TD) Clinical Trial
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials